Last week, CVS Health CEO Karen Lynch was pushed out of a role that had made her the most powerful woman in American business for years, atop a company with 2023 revenue of $358 billion.
The company's poor financial performance last quarter and weak profit forecast proved to be the last straw for the CVS board. It had tired of her inability to successfully bring together the different business components of a company that, through a slew of expensive M&A deals, had become a Frankenstein.
